Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 3
2009 6
2010 4
2011 12
2012 4
2013 9
2014 12
2015 11
2016 4
2017 3
2021 1
2022 1
2023 2
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Østergaard M, van Vollenhoven RF, Rudin A, Hetland ML, Heiberg MS, Nordström DC, Nurmohamed MT, Gudbjornsson B, Ørnbjerg LM, Bøyesen P, Lend K, Hørslev-Petersen K, Uhlig T, Sokka T, Grondal G, Krabbe S, Lindqvist J, Gjertsson I, Glinatsi D, Kapetanovic MC, Aga AB, Faustini F, Parmanne P, Lorenzen T, Giovanni C, Back J, Hendricks O, Vedder D, Rannio T, Grenholm E, Ljoså MK, Brodin E, Lindegaard H, Söderbergh A, Rizk M, Kastbom A, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Bay Laurbjerg T, Bakland G, Olsen IC, Haavardsholm EA, Lampa J; NORD-STAR study group. Østergaard M, et al. Among authors: boyesen p. Ann Rheum Dis. 2023 Oct;82(10):1286-1295. doi: 10.1136/ard-2023-224116. Epub 2023 Jul 9. Ann Rheum Dis. 2023. PMID: 37423647 Clinical Trial.
The OMERACT MRI inflammatory arthritis group: advances and future research priorities.
Conaghan PG, Bird P, McQueen F, Peterfy C, Bøyesen P, Gandjbakhch F, Duer-Jensen A, Haavardsholm EA, Ejbjerg B, Wiell C, Coates L, Hermann KG, O'Connor P, Lassere M, Freeston JE, Anandarajah A, Genant H, Emery P, Ostergaard M. Conaghan PG, et al. Among authors: boyesen p. J Rheumatol. 2009 Aug;36(8):1803-5. doi: 10.3899/jrheum.090349. J Rheumatol. 2009. PMID: 19671816
Update on research and future directions of the OMERACT MRI inflammatory arthritis group.
Conaghan PG, McQueen FM, Bird P, Peterfy CG, Haavardsholm EA, Gandjbakhch F, Bøyesen P, Coates L, Ejbjerg B, Eshed I, Foltz V, Hermann KG, Freeston J, Lillegraven S, Lassere M, Wiell C, Anandarajah A, Duer-Jensen A, O'Connor P, Genant HK, Emery P, Ostergaard M. Conaghan PG, et al. Among authors: boyesen p. J Rheumatol. 2011 Sep;38(9):2031-3. doi: 10.3899/jrheum.110419. J Rheumatol. 2011. PMID: 21885512 Review.
The OMERACT MRI in Arthritis Working Group - Update on Status and Future Research Priorities.
Østergaard M, Bird P, Gandjbakhch F, Eshed I, Haugen IK, Haavardsholm EA, Lillegraven S, Foltz V, Glinatsi D, Peterfy C, Ejbjerg B, Bøyesen P, Mease PJ, Hermann KG, Emery P, Genant HK, Conaghan PG. Østergaard M, et al. Among authors: boyesen p. J Rheumatol. 2015 Dec;42(12):2470-2. doi: 10.3899/jrheum.141248. Epub 2015 Feb 15. J Rheumatol. 2015. PMID: 25684771 Review.
The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA Hands.
Ostergaard M, McQueen F, Wiell C, Bird P, Bøyesen P, Ejbjerg B, Peterfy C, Gandjbakhch F, Duer-Jensen A, Coates L, Haavardsholm EA, Hermann KG, Lassere M, O'Connor P, Emery P, Genant H, Conaghan PG. Ostergaard M, et al. Among authors: boyesen p. J Rheumatol. 2009 Aug;36(8):1816-24. doi: 10.3899/jrheum.090352. J Rheumatol. 2009. PMID: 19671819
58 results